This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment of primary closed angle glaucoma/acute angle closure and angle closure glaucoma

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Latent closed angle glaucoma is treated only if provocative tests are positive or if one eye has previously experienced a subacute or acute attack. Subacute closed angle glaucoma is managed as the acute presentation.

Treatment of acute closed angle glaucoma:

  • urgent referral to an ophthalmology department
  • if unable to refer immediately
    • reduction of intra-ocular pressure by reducing aqueous secretion - acetazolamide, usually IV since the patient is often vomiting, and because a rapid response is required (1)
    • pupillary constriction - topical pilocarpine
  • management by ophthalmologists include:
    • medical – initial management is with intravenous acetazolamide and topical pilocarpine, beta-blockers, and steroids
    • surgical options includes iridotomy, phacoemulsification, or iridoplasty
      • laser peripheral iridotomy involves creating a small hole in the iris to alleviate pupillary blockage
      • opens up the drainage angle in the anterior chamber, relieving the condition

The anatomical configuration is invariably bilateral so prophylactic treatment of the other eye should be considered.

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.